Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Erin M McCartney und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Point-of-Care Testing, Hepatitis C, Prisons, Hepatitis C Antibodies. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Burnet Institute.
Abstract (Originalsprache)
Background
A barrier to hepatitis C virus (HCV) cure is conventional testing. The aim of this study was to evaluate the effect of HCV antibody and RNA point-of-care testing (POCT) on testing rates, linkage to care, treatment, and acceptability of testing in 3 priority settings in Australia.
Methods
Participants were enrolled in an interventional cohort study at a reception prison, inpatient mental health service, and inpatient alcohol and other drug unit, between October 2020 and December 2021. HCV POCT was performed using SD Bioline HCV antibody fingerstick test and a reflexive Xpert HCV Viral Load Fingerstick test using capillary blood samples. A retrospective audit of HCV testing and treatment data was performed at each site for the preceding 12-month period to generate a historical control.
Results
A total of 1549 participants received a HCV antibody test with 17% (264 of 1549) receiving a positive result, of whom 21% (55 of 264) tested HCV RNA positive. Across all settings the rate of testing per year significantly increased between the historical controls and the study intervention period by 2.57 fold (rate ratio, 2.57 [95% confidence interval, 2.32–2.85]) for HCV antibody testing and 1.62 (rate ratio, 1.62 [95% confidence interval, 1.31–2.01]) for RNA testing. Treatment uptake was higher during the POCT intervention (86% [47 of 55]; P = .01) compared to the historical controls (61% [27 of 44]).
Conclusions
This study demonstrated across 3 settings that the use of HCV antibody and RNA POCT increased testing rates, treatment uptake, and linkage to care. The testing model was highly acceptable for most participants. Clinical Trials Registration ACTRN-12621001578897
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- Disease Elimination, Burnet Institute, Melbourne, Victoria, Australia.
- Gastroenterolgy & Hepatology Department, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- Hepatology and Liver Transplantation Medicine Unit, Southern Adelaide Local Health Network, Adelaide, South Australia, Australia.
- Drug and Alcohol Services, Adelaide, SA Health, South Australia, Australia.
- Communicable Disease Control Branch, SA Health, Adelaide, South Australia, Australia.
ORCID-Profile: Erin M McCartney
Förderung
- Burnet Institute
Zitieren
APA
McCartney, E. M., Ralton, L., Dawe, J., Richmond, J., Zobel, J., Wigg, A., Cock, V., Tse, E. Y., Rees, T., Shaw, D., & Ferguson, C. (2024). Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae155
Vancouver
McCartney EM, Ralton L, Dawe J, Richmond J, Zobel J, Wigg A, et al. Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae155
BibTeX
@article{McCartney2024,
author = {McCartney, Erin M and Ralton, Lucy and Dawe, Joshua and Richmond, Jacqui and Zobel, Joshua and Wigg, Alan and Cock, Victoria and Tse, Edmund Y and Rees, Tom and Shaw, David and Ferguson, Catherine},
title = {Point-of-Care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons, and Drug and Alcohol Facilities—the PROMPt Study},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae155}
}
EUVIMED